These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1246336)

  • 61. [Activity of the complement system in nephropathies of childhood].
    Zelazko ME; Feldman G
    Medicina (B Aires); 1977; 37(3):205-14. PubMed ID: 895495
    [No Abstract]   [Full Text] [Related]  

  • 62. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
    Venge P; Olsson I
    J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity.
    Kim Y; Pallansch M; Carandente F; Reissmann G; Halberg E; Halberg F; Halberg F
    Chronobiologia; 1980; 7(2):189-204. PubMed ID: 7428510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy.
    Rahman MA; Liu CN; Dunn MJ; Emancipator SN
    Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Blood levels of the proactivator of the C 3 fraction of complement in glomerular nephropathies].
    Dall'Aglio P; Scarpioni L; Poisetti PG; Pantano E
    Minerva Nefrol; 1975; 22(6):262-5. PubMed ID: 1223703
    [No Abstract]   [Full Text] [Related]  

  • 66. Complement receptors in human renal glomeruli.
    Matre R; Tönder O
    Scand J Immunol; 1976; 5(4):437-41. PubMed ID: 951580
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Complement system in glomerulonephritis. 1. General aspects].
    Bodalski J; Jerzmanowski A; Narebska E
    Pediatr Pol; 1980 Jun; 55(6):797-803. PubMed ID: 6997826
    [No Abstract]   [Full Text] [Related]  

  • 69. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of nephritic factor as an immunoglobulin.
    Williams DG; Bartlett A; Duffus P
    Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
    Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
    Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.
    Fujita T; Takiuchi M; Iida K; Nagaki K; Inai S
    Immunochemistry; 1977 Jan; 14(1):25-30. PubMed ID: 849874
    [No Abstract]   [Full Text] [Related]  

  • 73. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ; He RJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):323-6. PubMed ID: 23591359
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of granulocyte neutral proteases on complement components.
    Johnson U; Ohlsson K; Olsson I
    Scand J Immunol; 1976; 5(4):421-6. PubMed ID: 181839
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common pathogenic mechanism.
    Corvillo F; López-Trascasa M
    Nefrologia (Engl Ed); 2018; 38(3):258-266. PubMed ID: 29279276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Membranoproliferative glomerulonephritis with partial lipodystrophy: discordant occurrence in identical twins.
    Reichel W; Köbberling J; Fischbach H; Scheler F
    Klin Wochenschr; 1976 Jan; 54(2):75-81. PubMed ID: 129586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunologic mechanisms in renal disease--an overview.
    Michael AF
    Nihon Jinzo Gakkai Shi; 1986 Jul; 28(7):873-86. PubMed ID: 3540388
    [No Abstract]   [Full Text] [Related]  

  • 78. C3, C4 and C5: the thioester site.
    Law SK; Dodds AW
    Biochem Soc Trans; 1990 Dec; 18(6):1155-9. PubMed ID: 2088831
    [No Abstract]   [Full Text] [Related]  

  • 79. Pathophysiology of the interaction between complement and non-complement proteases.
    Nydegger UE; Suter S
    Adv Exp Med Biol; 1984; 167():227-34. PubMed ID: 6369909
    [No Abstract]   [Full Text] [Related]  

  • 80. [The role of complement in membrano-proliferative glomerulonephritis (MPGN) (author's transl)].
    Ohi H
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1125-39. PubMed ID: 571029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.